kund
8 minutes ago
EMA is the slowest regulatory agency, bogged down by bureaucratic process. Coupled with the slowest CEO, there likely won’t be a decision before 2026. Even if approval is granted, the CEO will then need to negotiate separately with 27 EU countries, which is a nightmare scenario for a small biotech c